Brinzolamide CAS 138890-62-7: Potent Carbonic Anhydrase Inhibitor for Ophthalmic Use

A highly specific carbonic anhydrase inhibitor crucial for managing intraocular pressure and protecting vision.

Get a Quote & Sample

Key Advantages

Targeted Pressure Reduction

Brinzolamide effectively lowers intraocular pressure, a crucial step in glaucoma treatment, thereby improving patient outcomes.

Specific Mechanism of Action

As a highly specific carbonic anhydrase inhibitor, it offers a precise therapeutic effect with a favorable tolerability profile.

Vision Preservation

By managing intraocular pressure, brinzolamide helps prevent blindness and preserves visual function in patients with ocular conditions.

Key Applications

Glaucoma Management

Used to treat open-angle glaucoma, helping to prevent optic nerve damage and vision loss.

Ocular Hypertension

Effective in reducing elevated intraocular pressure that may lead to glaucoma.

Combination Therapies

Often used in conjunction with other medications like timolol or brimonidine for enhanced efficacy in controlling intraocular pressure.

Ophthalmic Formulations

Primarily formulated for topical ophthalmic use, ensuring targeted delivery and absorption.